购物车
您的购物车当前为空
别名 司沃妥塔单抗, SGN-B6A antibody
Sigvotatug是一种完全人源化的IgG1 κ单克隆抗体,靶向整合素β6(ITGB6)。该抗体可作为抗体药物偶联物(ADC)——Sigvotatug vedotin的抗体组分,可高特异性靶向整合素 αvβ6 阳性肿瘤细胞。

为众多的药物研发团队赋能,
让新药发现更简单!
Sigvotatug是一种完全人源化的IgG1 κ单克隆抗体,靶向整合素β6(ITGB6)。该抗体可作为抗体药物偶联物(ADC)——Sigvotatug vedotin的抗体组分,可高特异性靶向整合素 αvβ6 阳性肿瘤细胞。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,980 | 现货 | |
| 5 mg | ¥ 5,860 | 现货 | |
| 10 mg | ¥ 7,890 | 现货 | |
| 25 mg | ¥ 11,700 | 现货 | |
| 50 mg | ¥ 15,800 | 现货 |
| 产品描述 | Sigvotatug is a fully human IgG1 κ monoclonal antibody targeting integrin β6 (ITGB6). It can serve as the antibody component in the development of Sigvotatug vedotin, an antibody–drug conjugate (ADC) designed to selectively target integrin αvβ6–positive tumor cells through a highly specific, engineered antibody framework. |
| 别名 | 司沃妥塔单抗, SGN-B6A antibody |
| 反应种属 | Human |
| 应用 | ELISA FCM Functional assay |
| 抗体种类 | Monoclonal |
| 缓冲液 | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| 内毒素 | <1.0 EU/mg |
| 同型 | Human IgG1 kappa |
| 推荐同型对照 |
| 偶联 | Unconjugated |
| 基因ID | |
| Uniprot ID | |
| 靶点 | ITGB6 |
| 分子量 | 144.46 kDa |
| CAS No. | 2764774-90-3 |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice. |
对于不同动物的给药剂量换算,您也可以参考 更多